MX9605666A - Virus de hepatitis g y clonacion molecular del mismo. - Google Patents
Virus de hepatitis g y clonacion molecular del mismo.Info
- Publication number
- MX9605666A MX9605666A MX9605666A MX9605666A MX9605666A MX 9605666 A MX9605666 A MX 9605666A MX 9605666 A MX9605666 A MX 9605666A MX 9605666 A MX9605666 A MX 9605666A MX 9605666 A MX9605666 A MX 9605666A
- Authority
- MX
- Mexico
- Prior art keywords
- hgv
- hepatitis
- antigens
- methods
- virus
- Prior art date
Links
- 241000531123 GB virus C Species 0.000 title abstract 7
- 238000010369 molecular cloning Methods 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 3
- 102000036639 antigens Human genes 0.000 abstract 3
- 108091007433 antigens Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 108700026244 Open Reading Frames Proteins 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 208000006454 hepatitis Diseases 0.000 abstract 1
- 231100000283 hepatitis Toxicity 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Urology & Nephrology (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Oncology (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
Abstract
Se describen antigenos polipeptidicos los cuales son inmunoreactivos con sueros de individuos que tienen Hepatitis no-A, no-B, no-C, no-D, no-E, designados en la presente como virus de la Hepatitis G (HGV). Se enseño que las clonas de fragmentos genomicos correspondientes contienen polinucleotidos que codifican las secuencias de estructuras de lectura abierta por los polipéptidos antigénicos. Los antígenos son utiles en los métodos de diagnostico para detectar la presencia de HGV en sujetos de prueba. Los antígenos también son utiles en la preparacion de vacunas y anticuerpos. Además, se describen las secuencias completamente codificadas de dos HGV aislados. Se presentan métodos para la deteccion de HGV con base de ácido nucleico en muestras y también métodos para el aislamiento de secuencias genomicas adicionales correspondientes a HGV.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24698594A | 1994-05-20 | 1994-05-20 | |
US28555894A | 1994-08-03 | 1994-08-03 | |
US28554394A | 1994-08-03 | 1994-08-03 | |
US32972994A | 1994-10-26 | 1994-10-26 | |
US34427194A | 1994-11-23 | 1994-11-23 | |
US35750994A | 1994-12-16 | 1994-12-16 | |
US38988695A | 1995-02-15 | 1995-02-15 | |
PCT/US1995/006169 WO1995032291A2 (en) | 1994-05-20 | 1995-05-19 | Hepatitis g virus and molecular cloning thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9605666A true MX9605666A (es) | 1998-05-31 |
Family
ID=27569460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9605666A MX9605666A (es) | 1994-05-20 | 1995-05-19 | Virus de hepatitis g y clonacion molecular del mismo. |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0763114B1 (es) |
JP (2) | JPH10503642A (es) |
KR (1) | KR100394693B1 (es) |
CN (1) | CN1125877C (es) |
AT (1) | ATE210185T1 (es) |
CA (1) | CA2190860A1 (es) |
DE (1) | DE69524407T2 (es) |
DK (1) | DK0763114T3 (es) |
ES (1) | ES2170152T3 (es) |
FI (1) | FI112249B (es) |
HK (1) | HK1012412A1 (es) |
MX (1) | MX9605666A (es) |
NO (1) | NO323849B1 (es) |
NZ (1) | NZ288000A (es) |
PT (1) | PT763114E (es) |
WO (1) | WO1995032291A2 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6156495A (en) * | 1994-02-14 | 2000-12-05 | Abbott Laboratories | Hepatitis GB virus recombinant proteins and uses thereof |
US5981172A (en) * | 1994-02-14 | 1999-11-09 | Abbott Laboratories | Non-A, non-B, non-C, non-D, non-E Hepatitis reagents and methods for their use |
US6720166B2 (en) | 1994-02-14 | 2004-04-13 | Abbott Laboratories | Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use |
US6586568B1 (en) | 1994-02-14 | 2003-07-01 | Abbott Laboratories | Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
US5843450A (en) * | 1994-02-14 | 1998-12-01 | Abbott Laboratories | Hepatitis GB Virus synthetic peptides and uses thereof |
US6451578B1 (en) | 1994-02-14 | 2002-09-17 | Abbott Laboratories | Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
US6051374A (en) * | 1994-02-14 | 2000-04-18 | Abbott Laboratories | Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
US6558898B1 (en) | 1994-02-14 | 2003-05-06 | Abbott Laboratories | Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
US5955318A (en) * | 1995-08-14 | 1999-09-21 | Abbott Laboratories | Reagents and methods useful for controlling the translation of hepatitis GBV proteins |
US5709997A (en) * | 1995-08-14 | 1998-01-20 | Abbott Laboratories | Nucleic acid detection of hepatitis GB virus |
US5807670A (en) * | 1995-08-14 | 1998-09-15 | Abbott Laboratories | Detection of hepatitis GB virus genotypes |
ZA969715B (en) * | 1995-11-21 | 1998-05-20 | Boehringer Mannheim Gmbh | Amplification of nucleic acids and detection of a novel hepatitis Non-A/Non-B/Non-C/Non-D/Non-E virus. |
IT1283893B1 (it) * | 1996-01-24 | 1998-05-07 | Sorin Biomedica Diagnostics Sp | Metodo per rilevare sequenze nucleotidiche di virus associati a epatiti nona-none, peptidi e composizioni |
DE19613406A1 (de) * | 1996-04-03 | 1997-10-09 | Boehringer Mannheim Gmbh | Expression von HGV-Antigenen und deren Verwendung |
IT1284630B1 (it) * | 1996-04-17 | 1998-05-21 | Sorin Biomedica Diagnostics Sp | Epitopi specifici di virus associati a epatiti non"a"-non"e", composizioni e metodo per rivelare anticorpi di detti epitopi. |
US5766916A (en) * | 1996-04-24 | 1998-06-16 | Genelabs Technologies, Inc. | Hepatitis G virus protease |
EP0832901A1 (de) * | 1996-09-18 | 1998-04-01 | Roche Diagnostics GmbH | Antikörper gegen Hepatitis G-Virus und deren Verwendung zum diagnostischen Nachweis von HGV sowie als Therapeutikum |
JP2001522599A (ja) | 1997-11-06 | 2001-11-20 | イノジェネティックス・ナムローゼ・フェンノートシャップ | 診断用及びワクチン用、c型肝炎ウイルスエンベロープタンパク質由来マルチマーペプチド |
GB0009756D0 (en) * | 2000-04-19 | 2000-06-07 | Glaxo Group Ltd | Test method |
WO2014097762A1 (ja) * | 2012-12-20 | 2014-06-26 | 国立大学法人熊本大学 | 高病原性トリインフルエンザに対する抗体 |
US9594163B2 (en) | 2013-04-15 | 2017-03-14 | Electronics And Telecommunications Research Institute | Security and surveillance system and method |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990000597A1 (en) * | 1988-07-06 | 1990-01-25 | Genelabs Incorporated | Post-transfusion, non-a, non-b hepatitis virus and antigens |
WO1994018217A1 (en) * | 1993-02-03 | 1994-08-18 | Abbott Laboratories | Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
CA2166313A1 (en) * | 1994-02-14 | 1995-08-17 | John N. Simons | Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
-
1995
- 1995-05-19 JP JP7530387A patent/JPH10503642A/ja not_active Withdrawn
- 1995-05-19 ES ES95922085T patent/ES2170152T3/es not_active Expired - Lifetime
- 1995-05-19 PT PT95922085T patent/PT763114E/pt unknown
- 1995-05-19 DK DK95922085T patent/DK0763114T3/da active
- 1995-05-19 KR KR1019960706582A patent/KR100394693B1/ko not_active IP Right Cessation
- 1995-05-19 MX MX9605666A patent/MX9605666A/es unknown
- 1995-05-19 CA CA002190860A patent/CA2190860A1/en not_active Abandoned
- 1995-05-19 AT AT95922085T patent/ATE210185T1/de not_active IP Right Cessation
- 1995-05-19 CN CN95194249A patent/CN1125877C/zh not_active Expired - Fee Related
- 1995-05-19 EP EP95922085A patent/EP0763114B1/en not_active Expired - Lifetime
- 1995-05-19 WO PCT/US1995/006169 patent/WO1995032291A2/en active Search and Examination
- 1995-05-19 DE DE69524407T patent/DE69524407T2/de not_active Expired - Fee Related
- 1995-06-22 NZ NZ288000A patent/NZ288000A/en not_active IP Right Cessation
-
1996
- 1996-11-07 NO NO19964721A patent/NO323849B1/no not_active IP Right Cessation
- 1996-11-18 FI FI964605A patent/FI112249B/fi active
-
1998
- 1998-12-15 HK HK98113378A patent/HK1012412A1/xx not_active IP Right Cessation
-
2005
- 2005-11-02 JP JP2005320175A patent/JP4296174B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH10503642A (ja) | 1998-04-07 |
FI964605A (fi) | 1997-01-15 |
CN1125877C (zh) | 2003-10-29 |
JP4296174B2 (ja) | 2009-07-15 |
HK1012412A1 (en) | 1999-07-30 |
EP0763114A2 (en) | 1997-03-19 |
EP0763114B1 (en) | 2001-12-05 |
CN1153529A (zh) | 1997-07-02 |
KR970703425A (ko) | 1997-07-03 |
KR100394693B1 (ko) | 2003-12-31 |
WO1995032291A2 (en) | 1995-11-30 |
AU684177B2 (en) | 1997-12-04 |
DK0763114T3 (da) | 2002-04-02 |
NO964721D0 (no) | 1996-11-07 |
JP2006115845A (ja) | 2006-05-11 |
ES2170152T3 (es) | 2002-08-01 |
DE69524407T2 (de) | 2002-08-01 |
CA2190860A1 (en) | 1995-11-30 |
FI964605A0 (fi) | 1996-11-18 |
NO323849B1 (no) | 2007-07-09 |
AU2689595A (en) | 1995-12-18 |
WO1995032291A3 (en) | 1996-03-07 |
NZ288000A (en) | 1998-09-24 |
PT763114E (pt) | 2002-05-31 |
ATE210185T1 (de) | 2001-12-15 |
DE69524407D1 (de) | 2002-01-17 |
NO964721L (no) | 1997-01-17 |
FI112249B (fi) | 2003-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1012412A1 (en) | Hepatitis g virus and molecular cloning thereof | |
CA2079912A1 (en) | Hepatitis c virus epitopes | |
DK480889A (da) | Non-a, non-b, hepatitisvirus-antigenpeptid, cdna kodende derfor, fremgangsmaade til detektering deraf og bakteriestamme indeholdende et saadant cdna | |
KR960703136A (ko) | 탠덤 합성 hiv-1 펩티드들 | |
CA2047792A1 (en) | Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines | |
ZA912305B (en) | Novel vaccine | |
KR940703851A (ko) | E형 간염 바이러스 펩타이드 항원 및 항체(hepatitis e virus peptide antigens and antibodies) | |
CA2057052A1 (en) | Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof | |
WO1996021734A3 (en) | P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods | |
ATE109512T1 (de) | Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind. | |
WO1995032290A3 (en) | Non-a/non-b/non-c/non-d/non-e hepatitis agents and molecular cloning thereof | |
CA2075366A1 (en) | Immunologically active peptides or polypeptides from the parvovirus b19 | |
EP0879244A4 (en) | POLYPEPTIDES AND MYCOPLASM RECOMBINATION VACCINES | |
AU9629498A (en) | Method for the production of (poly)peptides by using truncated variants of the sv40 large t antigen with an intact n terminus | |
GR3015437T3 (en) | Non-a non-b sequences. | |
PT97428A (pt) | Processo para a preparacao de epitopos do virus da hepatite c | |
Bopp et al. | Comparative studies on novel protein antigens of streptococci of the serological group B | |
IT1241581B (it) | Peptidi sintetici contenenti sequenze di aminoacidi che definiscono epitopi immunoreattivi contro anticorpi umani anti hcv, utili per l'allestimento di dosaggi immunologici. | |
KR930000127A (ko) | 비(非)a 비(非)b형 간염 진단방법 및 백신 |